Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Medication-Induced Tactile Hallucinations

Medication Classes Associated with Tactile Hallucinations

  • Loxapine and other first-generation antipsychotics may cause tactile hallucinations as part of their side effect profile, according to the American College of Clinical Pharmacology 1
  • Chlorpromazine, used for nausea management, can induce hallucinations at doses of 12.5-25 mg 3-4 times daily, as reported by the World Journal of Emergency Surgery 2
  • Haloperidol, while used to treat delirium with hallucinations, can paradoxically cause hallucinations in some patients, with evidence from the World Journal of Emergency Surgery and Annals of Oncology 2, 3
  • Lorcaserin (Belviq), a serotonin receptor agonist used for weight management, can cause hallucinations by binding to 5-HT receptors, as found in Clinical Gastroenterology and Hepatology 4
  • Opioid rotation (switching to different opioids like fentanyl or methadone) may help manage opioid-associated hallucinations, with a response rate of 80-90%, according to Praxis Medical Insights 5
  • Benzodiazepines, particularly when used for delirium management, may paradoxically cause delirium with associated hallucinations, as reported by Annals of Oncology 3, 6
  • Corticosteroids are implicated as risk factors for delirium with potential hallucinations, according to Annals of Oncology 6
  • Anticholinergic medications can contribute to perceptual disturbances including tactile hallucinations, as found in Annals of Oncology 6

Clinical Presentation and Assessment

  • Delirium assessment should be performed using standardized tools like CAM-ICU or ICDSC when medication-induced hallucinations are suspected, as recommended by the World Journal of Emergency Surgery and Praxis Medical Insights 2, 5

Management Approach

  • In cases of antipsychotic-induced hallucinations, consider switching from first-generation to atypical antipsychotics like quetiapine, which has a lower risk of extrapyramidal side effects, as suggested by Annals of Oncology and Praxis Medical Insights 3, 1
  • For opioid-induced hallucinations, opioid rotation may be effective with 80-90% response rates, according to Praxis Medical Insights 5
  • Avoid combining multiple medications that can cause hallucinations, as this increases risk without clear additional benefit, as recommended by Praxis Medical Insights 5

Monitoring and Follow-up

  • Assess for other medication side effects that may accompany hallucinations, such as extrapyramidal symptoms with antipsychotics, as reported by Annals of Oncology 3
  • Consider underlying conditions that may predispose to medication-induced hallucinations, particularly in elderly patients, as suggested by Annals of Oncology 6